Overview

The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection

Status:
Completed
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
The study explores the efficacy of lopinavir plus ritonavir and arbidol in treating with novel coronavirus infection. As a result this study would provide evidence for the clinical usage of these drugs in the future .
Phase:
Phase 4
Details
Lead Sponsor:
Guangzhou 8th People's Hospital
Treatments:
Lopinavir
Ritonavir